CompletedPhase 1NCT02943850

CNS10-NPC-GDNF for the Treatment of ALS

Studying Amyotrophic lateral sclerosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Cedars-Sinai Medical Center
Principal Investigator
Robert H. Baloh, MD, PhD
Cedars-Sinai Medical Center
Intervention
Stem cell (HPC) implantation(biological)
Enrollment
18 enrolled
Eligibility
18 years · All sexes
Timeline
20172019

Study locations (1)

Collaborators

California Institute for Regenerative Medicine (CIRM)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02943850 on ClinicalTrials.gov

Other trials for Amyotrophic lateral sclerosis

Additional recruiting or active studies for the same condition.

See all trials for Amyotrophic lateral sclerosis

← Back to all trials